Dr. Massimo Cristofanilli Discusses the Value of Genomic Testing for Early Stage Breast Cancer (VIDEO)

Thomas Jefferson University

Caption

Genomic tests that determine the molecular subtype of a woman's breast cancer provide a more precise prognosis and valuable guidance on treatment options, according to recent research presented this year at the San Antonio Breast Cancer Symposium (SABCS).

Credit

Thomas Jefferson University

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.